Thienopyrimidinone NMDA receptor modulators and uses thereof
US10500205B2 · kind B2 · utility
9Cited by
2References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2016 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Dec 9, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the NMDA receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.